Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Cytotherapy. 2011 Aug 17;13(10):1269–1280. doi: 10.3109/14653249.2011.586997

Figure 2. In vitro immunosuppressive effects of CTLA4-Ig in MLC.

Figure 2

The MLC data from three pairs in Group 1 at different time points is presented as the mean and range of the percent inhibition of counts per minute (CPM) from triplicate experiments. MLCs were performed on pre-treatment blood samples. Percent inhibition was calculated as [1 − (CPM in the presence of CTLA4-Ig / CPM in the absence of CTLA4-Ig)] × 100%.

Abbreviation: MLC, mixed leukocyte culture.